Stem cell disease model clarifies bone cancer trigger

Using induced pluripotent stem cells , a team led by Mount Sinai researchers has gained new insight into genetic changes that may turn a well known anti-cancer signaling gene into a driver of risk for bone cancers , where the survival rate has not improved in 40 years despite treatment advances. The study results, published in the journal Cell , revolve around iPSCs, which since their 2006 discovery have enabled researchers to coax mature bodily cells to become like embryonic stem cells.

http://www.medicalnewstoday.com/releases/292218.php